Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pharmacogenetics, Emotional Reactivity and Smoking

Phase 2

Completed

Conditions: Tobacco Use Disorder
Smoking Cessation

Interventions: Drug: Placebo
Drug: Bupropion
Drug: Varenicline
Behavioral: Smoking Cessation Counseling

First Posted Date: 2007-07-26

Last Posted Date: 2021-05-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 646

Registration Number: NCT00507728

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin

Phase 1

Completed

Conditions: Liver Cancer
Advanced Solid Tumors

Interventions: Drug: Fluorouracil
Drug: Avastin
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2007-07-26

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 63

Registration Number: NCT00507585

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Gastrointestinal Stromal Tumors (GIST) Registry

Completed

Conditions: Gastrointestinal Stromal Tumors

Interventions: Other: GIST Registry

First Posted Date: 2007-07-26

Last Posted Date: 2012-08-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1800

Registration Number: NCT00507273

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Ambulatory Cancer Pain Management: A Feasibility Study

Completed

Conditions: Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-26

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT00507351

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Memorial Hermann Hospital, Houston, Texas, United States
🇺🇸
Michael E. DeBakey Veterans Administration Medical Center, Houston, Texas, United States

and more 1 locations

Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

Not Applicable

Completed

Conditions: Lymphoma
Fatigue
Leukemia

Interventions: Behavioral: Food Record
Other: Nutritional Consults

First Posted Date: 2007-07-26

Last Posted Date: 2014-12-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 10

Registration Number: NCT00507260

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

Not Applicable

Completed

Conditions: Oral Cancer

Interventions: Procedure: Fluorescence Spectroscopy

First Posted Date: 2007-07-26

Last Posted Date: 2018-01-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 381

Registration Number: NCT00507182

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Collection of Outcomes Data for Pregnant Patients With Cancer

Recruiting

Conditions: Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm

Interventions: Other: Medical Chart Review

First Posted Date: 2007-07-26

Last Posted Date: 2025-04-03

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 500

Registration Number: NCT00507572

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer

Phase 2

Completed

Conditions: Bladder Cancer

Interventions: Drug: Avastin
Drug: Cisplatin
Drug: Doxorubicin
Drug: Methotrexate
Drug: Vinblastine Sulfate

First Posted Date: 2007-07-25

Last Posted Date: 2016-03-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 60

Registration Number: NCT00506155

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Simple Versus Radical Hysterectomy for Stage I Cervical Cancer

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: Interview

First Posted Date: 2007-07-25

Last Posted Date: 2016-02-26

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 85

Registration Number: NCT00506376

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Phase 2

Terminated

Conditions: Hematological Malignancies
Leukemia
Myelodysplastic Syndrome
Lymphoma

Interventions: Drug: Mycophenolate Mofetil (MMF)
Drug: Thymoglobulin
Drug: Sirolimus
Procedure: Stem Cell Transplant

First Posted Date: 2007-07-25

Last Posted Date: 2020-09-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 13

Registration Number: NCT00506948

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy